MBX Biosciences, Inc. Common Stock (MBX) is a publicly traded Healthcare sector company. As of October 3, 2026, MBX trades at $58.54 with a market cap of $2.72B and a P/E ratio of -24.71. MBX moved +3.43% today. Year to date, MBX is +91.52%; over the trailing twelve months it is +249.31%. Its 52-week range spans $4.81 to $72.64. Analyst consensus is strong buy with an average price target of $90.43. Rallies surfaces MBX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for MBX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $58.54 |
| Market Cap | $2.72B |
| P/E Ratio | -24.71 |
| EPS | $-2.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $72.64 |
| 52-Week Low | $4.81 |
| Volume | 484.10K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-86.97M |
| Gross Margin | 0.00% |
7 analysts cover MBX: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $90.43.